Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Animal model study with mechanistic findings on arrhythmia reduction; lacks human validation and hard clinical outcomes needed for stronger evidence grading.
This is a preclinical materials science study reporting rational design and in vitro/in vivo characterization of a nanoagent; it raises mechanistic questions about nanoparticle performance but does not test efficacy against a comparator in any clinical or disease model.
A sound cross-sectional study in a large, well-characterized HBsAg-positive cohort with rigorous discrimination analysis, but cross-sectional design and surrogate endpoint (ultrasound steatosis) limit the strength; findings require prospective validation before clinical adoption.